Table 2.
Impact of the COVID-19 pandemic on initiation of Gynecologic Oncology care.
| Variable | Pre-COVID-19 | COVID-19 | P value | |
|---|---|---|---|---|
| N=527 (60) | N=358 (40) | |||
| Time from referral to initial appointment | Overall cohort | 19.1 (32.7) | 17.4 (20.4) | 0.334 |
| (days, mean +/− SD) | Cancer patients | 14.4 (12.5) | 13.9 (14.2) | 0.716 |
| Benign + pre-invasive | 22.3 (48.3) | 18.4 (23.7) | 0.243 | |
| Referral source | Emergency room | 14 (2.7) | 11 (3.1) | 0.023 |
| Inpatient hospital | 6 (1.1) | 7 (2.0) | ||
| Gynecologist | 375 (71.2) | 284 (79.3) | ||
| Outpatient PCP | 47 (8.9) | 25 (7.0) | ||
| Self | 24 (4.6) | 9 (2.5) | ||
| other | 61 (11.6) | 22 (6.2) | ||
| Appointment attendance | Attended | 444 (84.3) | 318 (88.8) | 0.060 |
| Rescheduled (cancel or no show) | 83 (15.8) | 40 (11.2) | ||
| Reason for appointment cancellation | Patient cancel, COVID-19 | 0 | 8 (21.1) | 0.042 |
| Patient cancel, unspecified | 57 (89.1) | 18 (47.4) | ||
| Provider cancelled | 4 (6.3) | 11 (28.9) | ||
| Other | 3 (4.7) | 1 (2.6) | ||